Machine Learning Tempus Receives U.S. FDA Approval for xT CDx, a NGS-Based In Vitro Diagnostic Device Business Wire May 2, 2023 xT CDx is the company’s first Premarket Approval from the FDA Tempus, a leader in artificial intelligence and precision medicine, announced that…